All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Completed, but no date Terminated||2014-004371-22||Phase IV study to assess, the effect of hepatic impairment on the pharmacokinetics of Thiotepa and the potential of Thiotepa to alter the QT interval in pedatric patients undergoing allogeneic haemato...||bad-data|
|Reported results||2015-001360-19||Prospective, phase II/III, randomized clinical study to compare BEGEDINA® versus "conventional treatment" for treating steroid resistant acute graft-versus host disease Studio clinico randomizzato ...||2018-07-31||due-trials|
|Exempt||2017-002715-34||A Phase I/II, open label, dose escalation study to investigate the pharmacokinetics, pharmacodynamics, safety and clinical activity of begelomab as an initial treatment of acute Graft-versus-Host Dise...||not-yet-due|
|Ongoing||2021-000898-83||A phase II, randomized, double-blind, placebo-controlled, two-period, crossover trial to assess the efficacy and safety of begelomab in combination with standard steroid and/or immunosuppressant thera...||not-yet-due|